Koers LivaNova PLC London S.E.
Aandelen
LIVN
GB00BYMT0J19
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 1,22 mld. 1,12 mld. | Omzet 2025 * | 1,28 mld. 1,18 mld. | Marktkapitalisatie | 3,31 mld. 3,05 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 39 mln. 35,99 mln. | Nettowinst (verlies) 2025 * | 91 mln. 83,98 mln. | EV/omzet 2024 * | 2,64 x |
Nettoliquiditeiten 2024 * | 102 mln. 94,33 mln. | Nettoliquiditeiten 2025 * | 231 mln. 213 mln. | EV/omzet 2025 * | 2,41 x |
K/w-verhouding 2024 * |
88,8
x | K/w-verhouding 2025 * |
35,7
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,87% |
Recentste transcriptie over LivaNova PLC
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 01-01-17 |
William Kozy
CHM | Chairman | 72 | 12-06-18 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 08-01-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 03-12-20 | |
Peter Wilver
BRD | Director/Board Member | 64 | 13-06-22 |
William Kozy
CHM | Chairman | 72 | 12-06-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,16% | 178 mld. | |
-1,23% | 107 mld. | |
-4,86% | 67,04 mld. | |
-4,28% | 47,23 mld. | |
+10,32% | 44,62 mld. | |
+9,25% | 42,5 mld. | |
+15,97% | 25,22 mld. | |
-5,88% | 24,14 mld. | |
-5,38% | 23,69 mld. |